asal air suction in the treatment of acute migraine headache

Not Applicable

• Conditions: Migraine

• Registration Number: SLCTR/2017/018
• Lead Sponsor: Dr. S.M. Rathnasiri Bandara

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 20 August 2024

Recruitment & Eligibility

• Status: Complete: follow up complete
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

1.Male and female school children

2.Age 16-19 years

3.Diagnosed with migraine according to the IHS-criteria ICHD-II
1.1: Migraine without aura [G43.0]
1.2: Migraine with aura [G43.1]

4.Complaint of a single migraine headache of moderate or severe intensity

Exclusion Criteria

1. History of cranial lesion or tumor

2. Recent nasal or sinus infective illness, trauma and runny nose

3. Smoking

4. Known to abuse alcohol or drugs

5. Females on hormonal therapy for any condition or illness

6. Diagnosed psychiatric illness
7. Any other acute or chronic illness

8. Participants on non-medical/non-nutritional treatment for migraine prevention such as acupuncture or psychotherapy.

9. Participants on current medical treatment for acute migraine or migraine prophylaxis

10. Non-provision of informed consent and/or having lack of understanding of the information regarding the study

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Headache relief (defined as reduction of headache pain intensity from severe or moderate migraine headache to mild or none) at 60 seconds post-application of the device - using a 10 point pain scale and a 4 point Glaxo visual analogue scale. [At 60 seconds post-application of the device and at the completion of 1, 2, 4, 6, 12 and 24 hours post–application of the device]<br>Change in severity of suborbital tenderness/ scalp tenderness due to migraine headache - - using a 10 point pain scale and a 4 point Glaxo visual analogue scale. [At 60 seconds post-application of the device and at the completion of 1, 2, 4, 6, 12 and 24 hours post–application of the device]<br>

Secondary Outcome Measures

Name	Time	Method
one [None]<br>